Cargando…

Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease

BACKGROUND & AIMS: Patients with acute decompensation and acute-on-chronic liver failure (AD/ACLF) have immune dysfunction, which increases their risk for infections; however, there are no effective treatments to restore their immune function. We investigated whether the potentially immune-resto...

Descripción completa

Detalles Bibliográficos
Autores principales:	China, Louise, Maini, Alexander, Skene, Simon S., Shabir, Zainib, Sylvestre, Yvonne, Colas, Romain A., Ly, Lucy, Becares Salles, Natalia, Belloti, Vittorio, Dalli, Jesmond, Gilroy, Derek W., O’Brien, Alastair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	W.B. Saunders for the American Gastroenterological Association 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168974/ https://www.ncbi.nlm.nih.gov/pubmed/28859868 http://dx.doi.org/10.1016/j.cgh.2017.08.027

Ejemplares similares

Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality
por: Becares, Natalia, et al.
Publicado: (2020)

Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial
por: China, Louise, et al.
Publicado: (2018)

ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial
por: China, Louise, et al.
Publicado: (2018)

ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial
por: China, Louise, et al.
Publicado: (2016)

Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis
por: China, Louise, et al.
Publicado: (2022)

Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway
por: Maini, Alexander A., et al.
Publicado: (2021)

Prolonged immune alteration following resolution of acute inflammation in humans
por: Motwani, Madhur P., et al.
Publicado: (2017)

CORRIGENDUM: Novel n-3 Immunoresolvents: Structures and Actions
por: Dalli, Jesmond, et al.
Publicado: (2014)

Novel n-3 Immunoresolvents: Structures and Actions
por: Dalli, Jesmond, et al.
Publicado: (2013)

Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy
por: Dakin, Stephanie G., et al.
Publicado: (2017)

Identification of resolvin D2 receptor mediating resolution of infections and organ protection
por: Chiang, Nan, et al.
Publicado: (2015)

Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators
por: Sobrino, Agua, et al.
Publicado: (2020)

13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
por: Walker, Mary E., et al.
Publicado: (2017)

Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis
por: Flak, Magdalena B., et al.
Publicado: (2019)

Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis
por: Flak, Magdalena B., et al.
Publicado: (2022)

Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli–driven acute inflammation
por: Motwani, Madhur P., et al.
Publicado: (2018)

Distinct immune profiles of HIV‐infected subjects are linked to specific lipid mediator signature
por: Sips, Magdalena, et al.
Publicado: (2022)

Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis
por: Colas, Romain A., et al.
Publicado: (2019)

Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease
por: Schaller, Melinda S., et al.
Publicado: (2020)

Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer
por: De Matteis, Roberta, et al.
Publicado: (2022)

A Comparison of Human Neutrophils Acquired from Four Experimental Models of Inflammation
por: Maini, Alexander A., et al.
Publicado: (2016)

Synthesis and Anti-inflammatory and Pro-resolving Activities of 22-OH-PD1, a Monohydroxylated Metabolite of Protectin D1
por: Tungen, Jørn E., et al.
Publicado: (2014)

Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis
por: Gomez, Esteban A., et al.
Publicado: (2020)

Immunoresolvents signaling molecules at intersection between the brain and immune system
por: Dalli, Jesmond, et al.
Publicado: (2018)

Pro-Resolving Mediators in Regulating and Conferring Macrophage Function
por: Dalli, Jesmond, et al.
Publicado: (2017)

Identification and structure elucidation of the pro‐resolving mediators provides novel leads for resolution pharmacology
por: Dalli, Jesmond, et al.
Publicado: (2018)

Reply to: Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples
por: Dalli, Jesmond, et al.
Publicado: (2023)

Total Synthesis of the Lipid Mediator PD1(n-3 DPA): Configurational Assignments and Anti-inflammatory and Pro-resolving Actions
por: Aursnes, Marius, et al.
Publicado: (2014)

Synthesis of 13(R)-Hydroxy-7Z,10Z,13R,14E,16Z,19Z Docosapentaenoic Acid (13R-HDPA) and Its Biosynthetic Conversion to the 13-Series Resolvins
por: Primdahl, Karoline G., et al.
Publicado: (2016)

HIF1α activation in dendritic cells under sterile conditions promotes an anti-inflammatory phenotype through accumulation of intracellular lipids
por: Wood, Elizabeth G., et al.
Publicado: (2020)

Bile duct‐ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differences
por: O'Brien, Alastair, et al.
Publicado: (2015)

Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins
por: Cianci, Eleonora, et al.
Publicado: (2016)

Loss of 15-lipoxygenase disrupts T(reg) differentiation altering their pro-resolving functions
por: Marques, Raquel M., et al.
Publicado: (2021)

A mosquito lipoxin/lipocalin complex mediates innate immune priming in Anopheles gambiae
por: Ramirez, Jose Luis, et al.
Publicado: (2015)

Proresolving Mediators LXB4 and RvE1 Regulate Inflammation in Stromal Cells from Patients with Shoulder Tendon Tears
por: Dakin, Stephanie G., et al.
Publicado: (2019)

Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the α7nAChR subunit
por: Caravaca, April S., et al.
Publicado: (2022)

Author Correction: A mosquito lipoxin/lipocalin complex mediates innate immune priming in Anopheles gambiae
por: Ramirez, Jose Luis, et al.
Publicado: (2023)

Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
por: Dalli, Jesmond, et al.
Publicado: (2015)

Lipid mediators in immune dysfunction after severe inflammation()
por: Fullerton, James N., et al.
Publicado: (2014)

Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation
por: Abdulnour, Raja Elie E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nlck1q61b98pntekqcdbr010v8